Aurobindo Pharma (ARBP IN) – Q4FY25 Result Update – Resumption of PenG plant remains key trigger – BUY
Published on 27 May 2025
-
Broking & Distribution
02266322222
- Wealth Management
-
Asset Management
02266322222
- Investment Banking
- Institutional Equities
- Securities Finance
